Dean B. Reardon

1.7k citations

23 papers · 1.4k indexed · h-index 18

Molecular Biology top 10%
Oncology top 5%
Pulmonary and Respiratory Medicine top 10%
Cancer Research top 10%
Radiology, Nuclear Medicine and Imaging top 10%

Co-authors: Paul Dent Rupert Schmidt‐Ullrich Kristoffer Valerie Geoffrey Bowers Ross B. Mikkelsen Thomas W. Sturgill Joseph N. Contessa Craig D. Logsdon
Topics: Melanoma and MAPK Pathways (6 papers)Cancer-related Molecular Pathways (6 papers)Protein Tyrosine Phosphatases (4 papers)
Cited by: Oncology Cancer Research Molecular Biology
Journals: Journal of Biological Chemistry Journal of Clinical Oncology Molecular and Cellular Biology
Partner nations: United States Germany Australia

In The Last Decade

Dean B. Reardon

23 papers receiving 1.4k citations

Peers

Countries citing papers authored by Dean B. Reardon

Since Specialization

Citations

This map shows the geographic impact of Dean B. Reardon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dean B. Reardon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dean B. Reardon more than expected).

Fields of papers citing papers by Dean B. Reardon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dean B. Reardon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dean B. Reardon. The network helps show where Dean B. Reardon may publish in the future.

Co-authorship network of co-authors of Dean B. Reardon

This figure shows the co-authorship network connecting the top 25 collaborators of Dean B. Reardon. A scholar is included among the top collaborators of Dean B. Reardon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dean B. Reardon. Dean B. Reardon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	2903 Identifying the correct patient (pt) population for ABT-414: Biomarker assays for epidermal growth factor receptor (EGFR) in pts with glioblastoma (GBM) 2015 ·European Journal of Cancer ·Martin J. van den Bent,Lisa Roberts-Rapp,Peter Ansell,(unknown),Min Song,И. А. Соколова,Hui Gan,K. Papadopoulos,Andrew B. Lassman,Ryan Merrell,Priya Kumthekar,(unknown),Erica Gomez,(unknown),Anahita Bhathena,Kyle D. Holen,Renchun Lai,Dean B. Reardon	2
2	Pazopanib and lapatinib in patients with relapsed malignant glioma: Results of a phase I/II study 2009 ·Journal of Clinical Oncology ·Sophia Frentzas,Morris D. Groves,Jorge Barriuso,(unknown),Dean B. Reardon,(unknown),A. Benjamin Suttle,Bo Ma,Joanne Lager,Johann S. de Bono	9
3	Calcitonin increases invasiveness of prostate cancer cells: Role for cyclic AMP-dependent protein kinase A in calcitonin action 2005 ·International Journal of Cancer ·Venkata Sabbisetti,(unknown),Shibu Thomas,Kedar S. Vaidya,Dean B. Reardon,Maurizio Chiriva‐Internati,Kenneth A. Iczkowski,Girish V. Shah	35
4	A phase I study of AEE788, a novel multitargeted inhibitor of ErbB and VEGF receptor family tyrosine kinases, in recurrent GBM patients 2005 ·Journal of Clinical Oncology ·Dean B. Reardon,Timothy F. Cloughesy,C. Conrad,Michael Prados,Jingbo Xia,William Mietlowski,Michael J. Dugan,Paul S. Mischel,Henry S. Friedman,Andrew Yung	22
5	Epidermal Growth Factor Receptor as a Genetic Therapy Target for Carcinoma Cell Radiosensitization 2001 ·JNCI Journal of the National Cancer Institute ·Guido Lammering,(unknown),William Hawkins,Joseph N. Contessa,Dean B. Reardon,Peck‐Sun Lin,Kristoffer Valerie,Paul Dent,Ross B. Mikkelsen,Rupert Schmidt‐Ullrich	78
6	Recombinant adenoviral expression of dominant-negative ras N17 blocking radiation-induced activation of mitogen-activated protein kinase pathway 2001 ·Methods in enzymology on CD-ROM/Methods in enzymology ·Paul Dent,Craig D. Logsdon,Barbara Nicke,Kristoffer Valerie,Julie Farnsworth,Rupert Schmidt‐Ullrich,Dean B. Reardon	2
7	The relative role of ErbB1–4 receptor tyrosine kinases in radiation signal transduction responses of human carcinoma cells 2001 ·Oncogene ·Geoffrey Bowers,Dean B. Reardon,(unknown),Paul Dent,Ross B. Mikkelsen,Kristoffer Valerie,Guido Lammering,Cyrus Amir,Rupert Schmidt‐Ullrich	132
8	The vitamin D3 analog EB 1089 enhances the antiproliferative and apoptotic effects of adriamycin in MCF-7 breast tumor cells 2000 ·Breast Cancer Research and Treatment ·Sujatha Sundaram,M. Ahmad Chaudhry,Dean B. Reardon,Mridula Gupta,David A. Gewirtz	56
9	Molecular mechanisms of radiation-induced accelerated repopulation 1999 ·Radiation Oncology Investigations ·Rupert Schmidt‐Ullrich,Joseph N. Contessa,Paul Dent,Ross B. Mikkelsen,Kristoffer Valerie,Dean B. Reardon,Geoffrey Bowers,Peck‐Sun Lin	85
10	Roles for Basal and Stimulated p21^{Cip-1/WAF1/MDA6}Expression and Mitogen-activated Protein Kinase Signaling in Radiation-induced Cell Cycle Checkpoint Control in Carcinoma Cells 1999 ·Molecular Biology of the Cell ·Jong Sung Park,Stephen Carter,Dean B. Reardon,Rupert Schmidt‐Ullrich,Paul Dent,Paul B. Fisher	43
11	Dominant negative EGFR-CD533 and inhibition of MAPK modify JNK1 activation and enhance radiation toxicity of human mammary carcinoma cells 1999 ·Oncogene ·Dean B. Reardon,Joseph N. Contessa,Ross B. Mikkelsen,Kristoffer Valerie,Cyrus Amir,Paul Dent,Rupert Schmidt‐Ullrich	108
12	Radiation-induced Release of Transforming Growth Factor α Activates the Epidermal Growth Factor Receptor and Mitogen-activated Protein Kinase Pathway in Carcinoma Cells, Leading to Increased Proliferation and Protection from Radiation-induced Cell Death 1999 ·Molecular Biology of the Cell ·Paul Dent,Dean B. Reardon,Jong Sung Park,Geoffrey Bowers,Craig D. Logsdon,Kristoffer Valerie,Rupert Schmidt‐Ullrich	279
13	Molecular mechanisms of radiation‐induced accelerated repopulation 1999 ·Radiation Oncology Investigations ·Rupert Schmidt‐Ullrich,Joseph N. Contessa,Paul Dent,Ross B. Mikkelsen,Kristoffer Valerie,Dean B. Reardon,Geoffrey Bowers,Peck‐Sun Lin	4
14	Inhibition of the mitogen activated protein (MAP) kinase cascade potentiates cell killing by low dose ionizing radiation in A431 human squamous carcinoma cells 1998 ·Oncogene ·(unknown),Kelly L. Auer,Dean B. Reardon,Michael J. Birrer,Paul B. Fisher,Kristoffer Valerie,Rupert Schmidt‐Ullrich,Ross B. Mikkelsen,Paul Dent	133
15	S49 Cells Endogenously Express Subtype 2 Somatostatin Receptors Which Couple to Increase Protein Tyrosine Phosphatase Activity in Membranes and Down-regulate Raf-1 Activity In Situ 1997 ·Cellular Signalling ·Paul Dent,Yining Wang,(unknown),Steven L. Wood,Dean B. Reardon,Ramón Mangues,Àngel Pellicer,Agnes Schönbrunn,Thomas W. Sturgill	18
16	ActivationIn Vitroof Somatostatin Receptor Subtypes 2, 3, or 4 Stimulates Protein Tyrosine Phosphatase Activity in Membranes from Transfected Ras-Transformed NIH 3T3 Cells: Coexpression with Catalytically Inactive SHP-2 Blocks Responsiveness 1997 ·Molecular Endocrinology ·Dean B. Reardon,Paul Dent,Steven L. Wood,Ting Kong,Thomas W. Sturgill	70
17	Inactivation of Raf-1 by a Protein-tyrosine Phosphatase Stimulated by GTP and Reconstituted by Gαi/o Subunits 1996 ·Journal of Biological Chemistry ·Paul Dent,Dean B. Reardon,Steven L. Wood,Margaret A. Lindorfer,Stephen G. Graber,James C. Garrison,David L. Brautigan,Thomas W. Sturgill	33
18	Regulation of Raf-1 and Raf-1 Mutants by Ras-Dependent and Ras-Independent Mechanisms In Vitro 1995 ·Molecular and Cellular Biology ·Paul Dent,Dean B. Reardon,Deborah K. Morrison,Thomas W. Sturgill	120
19	Downstream signal transduction defects that suppress transformation in two revertant cell lines expressing activated rat neu oncogene. 1993 ·Journal of Biological Chemistry ·Dean B. Reardon,Mien‐Chie Hung	4
20	DNA polymerase action on bulky deoxyguanosine and deoxyadenosine adducts 1990 ·Carcinogenesis ·Dean B. Reardon,C. Anita H. Bigger,Anthony Dipple	25

About Dean B. Reardon

Dean B. Reardon is a scholar working on Oncology, Toxicology and Genetics, having authored 23 papers that have together received 1.4k indexed citations. Recurring topics across this work include Melanoma and MAPK Pathways (6 papers), Cancer-related Molecular Pathways (6 papers) and Protein Tyrosine Phosphatases (4 papers). The work is most often cited by research in Oncology (595 citations), Cancer Research (232 citations) and Molecular Biology (791 citations). Dean B. Reardon has collaborated with scholars based in United States, Germany and Australia. Frequent co-authors include Paul Dent, Rupert Schmidt‐Ullrich, Kristoffer Valerie, Geoffrey Bowers, Ross B. Mikkelsen, Thomas W. Sturgill, Joseph N. Contessa, Craig D. Logsdon, Jong Sung Park and Cyrus Amir. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Molecular and Cellular Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact